๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Progress in the prevention and control of viral hepatitis type B

โœ Scribed by A. Mele; M. Rizzetto; T. Stroffolini; A. Zanetti


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
14 KB
Volume
67
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Progress in the prevention and control o
โœ Mario Rizzetto; Alessandro R. Zanetti ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 53 KB

## Abstract Hepatitis type B remains an important disease globally. Rapid advances have been made during the last two decades in the understanding of the biology of HBV, the complex interaction between the virus and the host, and the pathology and the clinical aspects of infection. Mass vaccination

Prevention and control of hepatitis B in
โœ Zongtang Sun; Lihua Ming; Xu Zhu; Jianhua Lu ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 59 KB

## Abstract About 170 million Chinese are infected chronically with HBV and 10% suffer from chronic hepatitis. Around half a million Chinese die from hepatitis B caused hepatocellular carcinoma and endstage cirrhosis each year. From 1983 to the present, a controlled clinical trial involving 80,000

Detection of hepatitis B virus DNA level
โœ Shou-Dong Lee; Jaw-Ching Wu; Jiin-Yu Wang; Yang-Te Tsai; Kwang-Juei Lo; Benjamin ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 241 KB ๐Ÿ‘ 2 views

apologize for giving the wrong Rojkind reference. For historical interest, we used the 1976 (3) publication, but by error, referred to the 1979 one ( 1). Dr. W. J. Lindblad makes an excellent point. The methods section was markedly abbreviated and the paper, as published, does give the misleading i

Institute of Medicine recommendations fo
โœ Abigail E. Mitchell; Heather M. Colvin; R. Palmer Beasley ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB

Despite federal, state, and local public health efforts to prevent and control hepatitis B virus (HBV) and hepatitis C virus (HCV) infections, these diseases remain serious health problems in the United States. About 1%-2% of the U.S. population has chronic HBV or HCV infections, and each year about

Hepatitis B viral markers in severe vira
โœ Harry B. Greenberg; William S. Robinson; C. Michael Knauer; Peter B. Gregory ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 386 KB

In our double-blind randomized trial of methylprednisolone vs. placebo in severe viral hepatitis, 16 patients with hepatitis B (8 on steroid, 8 on placebo) were followed for at least 4 weeks. Four of the eight patients receiving methylprednisolone eventually died and all patients on placebo survived